source
- STAT+: Pharmalittle: We’re reading about obesity drugs and a compounding list, an AstraZeneca setback, and moreThe FDA proposed excluding the active ingredients in popular obesity and diabetes drugs from a list of substances that can be used for compounded versionsSTAT · 3mo ago↗ source
- PFAS is still in some infant formulaCasey Means out as surgeon general nominee, America's renewed fertility anxiety, and more health newsSTAT · 3mo ago↗ source
- Summit slips on ivonescimab's apparent interim miss in sign of investor frustrationSummit Therapeutics’ stock price {$SMMT} tumbled nearly 20% after the closing bell Thursday afternoon, following an apparent statistical miss in part of a Phase 3 trial for its cancer drug ivonesci…Endpoints · 3mo ago